AMY KNIGHT: Open Payments
NPI 1164807723 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 13 payments from 7 companies in 2025. Trend: 2023 $1,214 · 2024 $293 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Melinta Therapeutics, LLC | 4 | $169 |
| Paratek Pharmaceuticals, Inc. | 1 | $112 |
| MIMEDX Group, Inc. | 3 | $61 |
| ABBVIE INC. | 2 | $40 |
| Solventum Corporation | 1 | $20 |
| Smith+Nephew, Inc. | 1 | $18 |
| ConvaTec Inc. | 1 | $15 |
Products named: Kimyrsa, NUZYRA, DALVANCE, ACTIV.A.C., COLLAGENASE SANTYL, TEFLARO, AQUACEL FOAM.
Industry payments across LA — which companies pay providers there.
